Abstract
Purpose
The frequency of detection of HBV co-infection with multiple HBV genotypes is influenced by the detection method; usually co-infections are detected by multiplex PCR or hybridization assays, and are rarely confirmed by sequencing and conventional cloning. The objective of this study was to confirm by ultra-deep pyrosequencing (UDPS) mixed HBV infections, previously detected by multiplex-nested PCR.
Methods
Sixteen samples from HBV co-infected Sudanese patients detected by multiplex-nested PCR, were amplified targeting the P/S region and sequenced by UDPS.
Results
The only genotypes identified using UDPS were D and E, while A, B, C and F genotypes, previously detected by multiplex-nested PCR, were not detected. Specifically, 10 samples were shown to be mono-infected (D or E); in 3 out of 10 mono-infected D patients, a subtype combination was observed: D1 + D7 in 2 cases and D2 + D6 in 1 case. The remaining 6 subjects were D + E co-infected (harboring different mixtures of D subtypes).
Conclusions
Overall, UDPS is more effective than multiplex-nested PCR for identifying multiple HBV genotypes and subtypes infections.
Similar content being viewed by others
References
Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology. 2014;57:141–50. https://doi.org/10.1159/000360947.
Norder H, Couroucé A-M, Coursaget P, Echevarria JM, Lee S-D, Mushahwar IK, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004;47:289–309. https://doi.org/10.1159/000080872.
Santos AO, Alvarado-Mora MV, Botelho L, Vieira DS, Pinho JRR, Carrilho FJ, et al. Characterization of hepatitis B virus (HBV) genotypes in patients from Rondônia, Brazil. Virol J. 2010;7:315. https://doi.org/10.1186/1743-422X-7-315.
Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol. 2000;81:67–74. https://doi.org/10.1099/0022-1317-81-1-67.
Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol. 2002;83:2059–73. https://doi.org/10.1099/0022-1317-83-8-2059.
Hess G, Arnold W, Koesters W, Biswas R, Hütteroth TH, zum Büschenfelde KH. Simultaneous presence of HBsAg and anti-HBs in the serum of different subtypes (serological and immunofluorescent studies). Z Immunitatsforsch Immunobiol. 1977;153:143–51.
Tabor E, Gerety RJ, Smallwood LA, Barker LF. Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum. J Immunol Baltim Md. 1950;1977:369–70.
Ding X, Gu H, Zhong Z-H, Zilong X, Tran HT-T, Iwaki Y, et al. Molecular epidemiology of hepatitis viruses and genotypic distribution of hepatitis B and C viruses in Harbin, China. Jpn J Infect Dis. 2003;56:19–22.
Kato H, Orito E, Sugauchi F, Ueda R, Koshizaka T, Yanaka S, et al. Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with type-specific probes immobilized on a solid-phase support. J Virol Methods. 2003;110:29–35.
Chen B-F, Kao J-H, Liu C-J, Chen D-S, Chen P-J. Genotypic dominance and novel recombinations in HBV genotype B and C co-infected intravenous drug users. J Med Virol. 2004;73:13–22. https://doi.org/10.1002/jmv.20051.
Candotti D, Diarra B, Bisseye C, Tao I, Pham Quang K, Sanou M, et al. Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: prevalence of quasi-subgenotype A3, genotype E, and mixed infections. J Med Virol. 2016;88:2145–56. https://doi.org/10.1002/jmv.24589.
Toan NL, Song LH, Kremsner PG, Duy DN, Binh VQ, Duechting A, et al. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. J Hepatol. 2006;45:361–9. https://doi.org/10.1016/j.jhep.2006.03.013.
Minosse C, Giombini E, Bartolini B, Capobianchi MR, Garbuglia AR. Ultra-deep sequencing characterization of HCV samples with equivocal typing results determined with a commercial assay. Int J Mol Sci. 2016;17:1679. https://doi.org/10.3390/ijms17101679.
Chien R-N, Yeh C-T, Tsai S-L, Chu C-M, Liaw Y-F. Determinants for sustained HBeAg response to lamivudine therapy. Hepatol Baltim Md. 2003;38:1267–73. https://doi.org/10.1053/jhep.2003.50458.
Kobayashi M, Suzuki F, Akuta N, Suzuki Y, Arase Y, Ikeda K, et al. Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C. J Med Virol. 2006;78:1276–83. https://doi.org/10.1002/jmv.20701.
Osiowy C, Villeneuve J-P, Heathcote EJ, Giles E, Borlang J. Detection of rtN236T and rtA181 V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J Clin Microbiol. 2006;44:1994–7. https://doi.org/10.1128/JCM.02477-05.
Bonino F, Marcellin P, Lau GKK, Hadziyannis S, Jin R, Piratvisuth T, et al. Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B. Gut. 2007;56:699–705. https://doi.org/10.1136/gut.2005.089722.
Chauhan R, Singh AK, Rooge S, Varshney A, Kumar M, Sarin SK. Analysis of hepatitis B virus genotype changes in patients with chronic hepatitis B infection on tenofovir therapy. J Med Virol. 2016;88:1364–75. https://doi.org/10.1002/jmv.24489.
Naito H, Hayashi S, Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol. 2001;39:362–4. https://doi.org/10.1128/JCM.39.1.362-364.2001.
Caballero A, Gregori J, Homs M, Tabernero D, Gonzalez C, Quer J, et al. Complex genotype mixtures analyzed by deep sequencing in two different regions of hepatitis B virus. PLoS One. 2015;10:e0144816. https://doi.org/10.1371/journal.pone.0144816.
Vincenti D, Piselli P, Solmone M, D’Offizi G, Capobianchi MR, Menzo S. Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002–2012) of different treatment regimens: the legacy of lamivudine/adefovir combination treatment. Antiviral Res. 2017;143:62–8. https://doi.org/10.1016/j.antiviral.2017.03.008.
Zhang Q, Wu G, Richards E, Jia S, Zeng C. Universal primers for HBV genome DNA amplification across subtypes: a case study for designing more effective viral primers. Virol J. 2007;4:92. https://doi.org/10.1186/1743-422X-4-92.
Li W, Jaroszewski L, Godzik A. Clustering of highly homologous sequences to reduce the size of large protein databases. Bioinforma Oxf Engl. 2001;17:282–3.
Ramírez C, Gregori J, Buti M, Tabernero D, Camós S, Casillas R, et al. A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model. Antiviral Res. 2013;98:273–83. https://doi.org/10.1016/j.antiviral.2013.03.007.
Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–7. https://doi.org/10.1093/nar/gkh340.
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725–9. https://doi.org/10.1093/molbev/mst197.
Yousif M, Mudawi H, Bakhiet S, Glebe D, Kramvis A. Molecular characterization of hepatitis B virus in liver disease patients and asymptomatic carriers of the virus in Sudan. BMC Infect Dis. 2013;13:328. https://doi.org/10.1186/1471-2334-13-328.
Yousif M, Mudawi H, Hussein W, Mukhtar M, Nemeri O, Glebe D, et al. Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2014;29:125–32. https://doi.org/10.1016/j.ijid.2014.07.002.
Mahgoub S, Candotti D, El Ekiaby M, Allain J-P. Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol. 2011;49:298–306. https://doi.org/10.1128/JCM.00867-10.
Coppola N, Onorato L, Minichini C, Di Caprio G, Starace M, Sagnelli C, et al. Clinical significance of hepatitis B surface antigen mutants. World J Hepatol. 2015;7:2729–39. https://doi.org/10.4254/wjh.v7.i27.2729.
Lim CK, Tan JTM, Ravichandran A, Chan YC, Ton SH. Comparison of PCR-based genotyping methods for hepatitis B virus. Malays J Pathol. 2007;29:79–90.
Sertoz RY, Erensoy S, Pas S, Akarca US, Ozgenc F, Yamazhan T, et al. Comparison of sequence analysis and INNO-LiPA HBV DR line probe assay in patients with chronic hepatitis B. J Chemother Florence Italy. 2005;17:514–20. https://doi.org/10.1179/joc.2005.17.5.514.
Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol. 1998;143:2313–26.
Venegas M, Muñoz G, Hurtado C, Alvarez L, Velasco M, Villanueva RA, et al. Prevalence of hepatitis B virus genotypes in chronic carriers in Santiago, Chile. Arch Virol. 2008;153:2129–32. https://doi.org/10.1007/s00705-008-0231-6.
Bekondi C, Olinger CM, Boua N, Talarmin A, Muller CP, Le Faou A, et al. Central African Republic is part of the West-African hepatitis B virus genotype E crescent. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2007;40:31–7. https://doi.org/10.1016/j.jcv.2007.05.009.
Repp R, Rhiel S, Heermann KH, Schaefer S, Keller C, Ndumbe P, et al. Genotyping by multiplex polymerase chain reaction for detection of endemic hepatitis B virus transmission. J Clin Microbiol. 1993;31:1095–102.
Ehrich M, Böcker S, van den Boom D. Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS. Nucleic Acids Res. 2005;33:e38. https://doi.org/10.1093/nar/gni038.
Bekondi C, Olinger CM, Boua N, Talarmin A, Venard V, Muller CP, et al. Characterization of hepatitis B virus strains from the Central African Republic: preliminary results. Pathol Biol (Paris). 2008;56:310–3. https://doi.org/10.1016/j.patbio.2007.12.007.
Hübschen JM, Andernach IE, Muller CP. Hepatitis B virus genotype E variability in Africa. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2008;43:376–80. https://doi.org/10.1016/j.jcv.2008.08.018.
Yousif M, Kramvis A. Genotype D of hepatitis B virus and its subgenotypes: an update. Hepatol Res Off J Jpn Soc Hepatol. 2013;43:355–64. https://doi.org/10.1111/j.1872-034X.2012.01090.x.
Ochwoto M, Chauhan R, Gopalakrishnan D, Chen C-Y, Nganga Z, Okoth F, et al. Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis. 2013;20:103–10. https://doi.org/10.1016/j.meegid.2013.08.013.
Perrillo R. Benefits and risks of interferon therapy for hepatitis B. Hepatol Baltim Md. 2009;49:S103–11. https://doi.org/10.1002/hep.22956.
Acknowledgements
This work was supported by Italian Ministry of Health (funds Ricerca Corrente, linea 3 hepatitis to National Institute for Infectious Diseases INMI IRCCS L. Spallanzani); the European Union’s Horizon 2020 research and innovation program European Virus Archive goes Global under Grant agreement no. 653316.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Enan, K.A., Minosse, C., El Hussein, A.R.M. et al. Analysis of hepatitis B virus-mixed genotype infection by ultra deep pyrosequencing in Sudanese patients, 2015–2016. Infection 47, 793–803 (2019). https://doi.org/10.1007/s15010-019-01306-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-019-01306-5